- ISIN
- US68247Q1022
- CUSIP
- 68247Q102
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- IPO Date
- Sep 12, 2018
Highlights
- Market Cap
- $33.63M
- Enterprise Value
- $37.83M
- EPS (TTM)
- -CN¥8.62
- Total Revenue (TTM)
- CN¥11.35B
- Gross Profit (TTM)
- CN¥651.99M
- EBITDA (TTM)
- -CN¥18.04M
- Year Range
- $2.48 - $11.17
- ROA (TTM)
- -26.90%
- ROE (TTM)
- 70.44%
- Avg. Volume (1M)
- 9K
- Avg. Volume Value (1M)
- $35.30K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
YI Performance Chart
111, Inc. (YI) is up 50.4% since the beginning of the year. At $4 per share, YI is trading 65.5% below its 52-week high of $11. Investors who bought $1,000 worth of YI shares 5 years ago would now be looking at an investment worth $65.
Loading charts...
Compare this symbol against anything
Returns By Period
111, Inc. (YI) has returned 50.39% so far this year and -44.36% over the past 12 months.
111, Inc.
- 1D
- 0.00%
- 1M
- -6.78%
- 6M
- -47.26%
- YTD
- 50.39%
- 1Y
- -44.36%
- 3Y*
- -50.16%
- 5Y*
- -42.05%
- 10Y*
- —
- ALL TIME*
- -38.04%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
YI Monthly Returns History
Based on dividend-adjusted daily data since Sep 12, 2018, YI's average daily return is -0.04%, while the average monthly return is -0.91%.
Historically, 37% of months were positive and 63% were negative. The best month was Jan 2026 with a return of +185.2%, while the worst month was Dec 2018 at -35.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, YI closed higher 44% of trading days. The best single day was Sep 10, 2019 with a return of +62.0%, while the worst single day was Dec 4, 2018 at -25.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 185.16% | 8.36% | -17.57% | -4.91% | -14.84% | -17.80% | -11.29% | 50.39% | |||||
| 2025 | -6.58% | 52.41% | -8.57% | 1.97% | -1.21% | -12.60% | -3.79% | -6.40% | -29.24% | -3.96% | -15.10% | -31.00% | -58.91% |
| 2024 | -11.61% | -0.00% | -15.33% | -10.34% | 13.46% | -9.75% | 7.98% | -33.17% | -1.63% | -3.04% | 13.23% | -24.94% | -59.81% |
| 2023 | 0.99% | -11.15% | -2.21% | 2.87% | -8.66% | -1.22% | 29.29% | -20.13% | 2.36% | -15.77% | -9.13% | -22.11% | -48.68% |
| 2022 | -13.43% | -11.88% | -0.37% | -26.32% | 2.04% | 3.00% | 37.86% | 3.17% | -8.53% | 0.75% | 10.74% | 1.00% | -13.71% |
| 2021 | 58.56% | 77.31% | -29.38% | -9.71% | -21.91% | -6.63% | -35.17% | 4.41% | 0.33% | -15.72% | -25.96% | -9.09% | -49.64% |
Benchmark Metrics
111, Inc. has an annualized alpha of -18.63%, beta of 0.75, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since September 12, 2018.
- This stock participated in 163.78% of S&P 500 Index downside but only -24.43% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -18.63%
- Beta
- 0.75
- R²
- 0.03
- Upside Capture
- -24.43%
- Downside Capture
- 163.78%
Return for Risk
Risk / Return Rank
YI ranks 20 for risk / return — above 20% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for 111, Inc. (YI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| YI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.91 | ||
| Sortino ratioReturn per unit of downside risk | -2.41 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.25 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.68 | 2.00 | -2.68 |
| Martin ratioReturn relative to average drawdown | -1.21 | 8.49 | -9.70 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the 111, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the 111, Inc. was 99.06%, occurring on Dec 31, 2025. The portfolio has not yet recovered.
The current 111, Inc. drawdown is 98.59%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.06%Dec 2025 | 4y 10mo | — | 5y 5moFeb 2021 - now | — |
-86.27%Sep 2019 | 11mo 29d | 1y 5mo | 2y 5moSep 2018 - Feb 2021 | — |
-11.51%Feb 2021 | 1d | 4d | 5dFeb 2021 - Feb 2021 | — |
Drawdown Indicators
| YI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.06% | -56.78% | -42.28% |
Max Drawdown (1Y)Largest decline over 1 year | -65.12% | -9.10% | -56.02% |
Max Drawdown (3Y)Largest decline over 3 years | -91.63% | -18.90% | -72.73% |
Max Drawdown (5Y)Largest decline over 5 years | -96.81% | -25.43% | -71.38% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -98.59% | -1.58% | -97.01% |
Average DrawdownAverage peak-to-trough decline | -80.14% | -10.70% | -69.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.41% | 2.14% | +34.27% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of 111, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how 111, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for YI relative to other companies in the Pharmaceutical Retailers industry. Currently, YI has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with YI
Add 111, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with YI